Shanghai Fochon Pharmaceutical Co., Ltd.

Fochon Pharmaceuticals, Ltd.

Chongqing Fochon Pharmaceutical Co., Ltd.

Chinese Academy of Sciences

Fochon Biosciences, Ltd.

Lijun Yang

Weibo Wang

Xingdong Zhao

Rui Tan

Jing Sun

Haohan Tan

Xianlong Wang

Yanxin Liu

Tongshuang Li

Zhifang Chen

Ling Chen

Qihong Liu

Min Lin

Zuwen Zhou

Bin Liu

Lihua Jiang

Weipeng Zhang

Zhifu Li

Hongbin Liu

Yue Rong

Zongyao Zou

Li Linghu

Jian Ding

Meiyu Geng

Linghua Meng

Huajie Zhang

Chengxi He

Kai Ran

Shu Lin

Chuiliang Yu

Yuwei Gao

Yunling Wang

Hong Fu

Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Macrocyclic compounds as TRK kinases inhibitors

Provided are certain IDO inhibitors or pharmaceutically acceptable salts thereof which can inhibit enzymatic activity of indoleamine 2,3-dioxygenase (IDO) and may be useful for the treatment of diseases and disorders mediated by IDO. In addition, pharmaceutical compositions thereof and methods of use thereof are also provided.

Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase

Certain CDK4/6 inhibitors and pharmaceutically acceptable salts thereof are described. In particular, these compounds can inhibit kinase activity of CDK4/6 and may be useful for the treatment of hyper-proliferative diseases like cancer and inflammation. In addition, the pharmaceutical compositions thereof and methods of use thereof are also described.

Certain protein kinase inhibitors

Provided are certain compounds or pharmaceutically acceptable salts thereof which can inhibit kinase activity of Bruton's tyrosine kinase (BTK) and may be useful for the treatment of diseases like cancer, immunological disease and inflammation.

Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors

Provided are certain CDK4/6 inhibitors with the structure of formula (I), pharmaceutical compositions thereof, and methods of use therefor. The compounds are of the class of pyrimidin-2 amine derivatives, useful for the treatment of hyper-proliferative diseases. 

Certain protein kinase inhibitor

Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Growing community of inventors

Chongqing, China

Lijun Yang